1
|
Jenca D, Jarolim P, Melenovsky V, Mrazkova J, Sramko M, Zelizko M, Kotrc M, Franekova J, Viczenova D, Adamkova V, Kautzner J, Wohlfahrt P. Interleukin-6 predicts recovery of systolic function after myocardial infarction. Eur J Prev Cardiol 2022. [DOI: 10.1093/eurjpc/zwac056.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry of Health of the Czech Republic
Background
Interleukin (IL)-6 is an important mediator of the inflammatory response to acute myocardial infarction (MI). Increased IL-6 levels are associated with adverse outcomes after MI. However, there are only limited data on the association of IL-6 levels with recovery of systolic function after MI.
Purpose
The aim of the present study was to evaluate the independent predictive value of IL-6 level for recovery of systolic function among patients hospitalized for their first MI.
Methods
Consecutive patients without previous history of MI or cardiomyopathy with left ventricular ejection fraction (LVEF) ≤40% measured by transthoracic echocardiography upon hospital discharge and available follow-up LVEF evaluated between 3 months and one year since hospital discharge were selected from a prospective registry of MI patients (n=1323).
Results
In total, data from 183 patients (mean age 64.2±11.2, 29% female, mean EF upon discharge 32.6±5.8) were analyzed. In the multivariate linear regression, IL-6 level measured within 24 hours from the hospital admission was positively associated with NT-proBNP, maximal hs-Troponin T a glycemia level and negatively with female gender, total cholesterol and admission systolic blood pressure. During follow-up, LVEF increased by 6.1±9.0% and LVEF recovered to value >50% in 43 (23.5%) patients. In the multivariate analysis, LVEF improvement was predicted by lower IL-6, lower maximal troponin level, female gender, lower heart rate at the time of hospital admission and Killip class I. In the ROC analysis (AUC 0.72, p<0.001), IL-6 ≤ 15.7ng/L had 51% sensitivity and 87% specificity to predict LVEF recovery.
Conclusion
The inflammatory response to MI, as assessed by IL-6, is associated with MI size, glucose and lipid metabolism and is lower in women. IL-6 independently predicts change in LVEF among patients with moderate to severe LV dysfunction. This supports previous findings that IL-6 inhibition can increase myocardial salvage after MI and identifies possible patients that may benefit from targeted therapy.
Collapse
Affiliation(s)
- D Jenca
- Institute for Clinical and Experimental Medicine; Third Faculty of Medicine, Charles University, Prague, Czechia
| | - P Jarolim
- Harvard Medical School, Department of Pathology, Brigham and Women’s Hospital, Boston, United States of America
| | - V Melenovsky
- Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia
| | - J Mrazkova
- Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia
| | - M Sramko
- Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia
| | - M Zelizko
- Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia
| | - M Kotrc
- Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia
| | - J Franekova
- Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia
| | - D Viczenova
- Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia
| | - V Adamkova
- Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia
| | - J Kautzner
- Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia
| | - P Wohlfahrt
- Institute for Clinical and Experimental Medicine; Third Faculty of Medicine, Charles University, Prague, Czechia
| |
Collapse
|
2
|
Satny M, Vrablik M, Franekova J, Vaingatova S, Kovar J. Plasmocellular Myeloma As A Cause Of Severe Mixed Dyslipidemia Accompanied By Hyperviscosity Syndrome. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
3
|
Kotrbaty J, Kotrbata M, Jabor A, Franekova J. Quality assessment of medical laboratories under the auspices of Czech Medical Association. Clin Chim Acta 2019. [DOI: 10.1016/j.cca.2019.03.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
4
|
Jabor A, Kubicek Z, Labanczova M, Viczenova D, Viklicky O, Caslavska M, Franekova J. Comparison of 3 inulin methods of GFR measurement and 5 methods of GFR estimation in living kidney donors. Clin Chim Acta 2019. [DOI: 10.1016/j.cca.2019.03.1033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
5
|
Melenovsky V, Kovar J, Pazdernik M, Hoskova L, Vrablik M, Franekova J, Kautzner J. P2805Elevated PCSK9 levels may contribute to dyslipidemia early after cardiac trasplantation. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p2805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- V Melenovsky
- Institute for clinical and experimental medicine, Prague, Czech Republic
| | - J Kovar
- Institute for clinical and experimental medicine, Prague, Czech Republic
| | - M Pazdernik
- Institute for clinical and experimental medicine, Prague, Czech Republic
| | - L Hoskova
- Institute for clinical and experimental medicine, Prague, Czech Republic
| | - M Vrablik
- Charles University of Prague, 1st Faculty of Medicine, 3rd Department of Medicine, Prague, Czech Republic
| | - J Franekova
- Institute for clinical and experimental medicine, Prague, Czech Republic
| | - J Kautzner
- Institute for clinical and experimental medicine, Prague, Czech Republic
| |
Collapse
|
6
|
Pazdernik M, Chen Z, Bedanova H, Kautzner J, Melenovsky V, Karmazin V, Malek I, Tomasek A, Ozabalova E, Krejci J, Franekova J, Wahle A, Zhang H, Kovarnik T, Sonka M. Detecting Early Cardiac Allograft Vasculopathy Using Highly Automated 3D Coronary Optical Coherence Tomography Segmentation Analysis. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.252] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
7
|
Sramko M, Wichterle D, Pavlov A, Gokdeniz T, Peichl P, Aldhoon B, Franekova J, Kautzner J. P1182Acute release of natriuretic peptides in atrial fibrillation is independent of left atrial hemodynamics. Europace 2018. [DOI: 10.1093/europace/euy015.666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- M Sramko
- Institute for Clinical and Experimental Medicine (IKEM), Department of Cardiology, Prague, Czech Republic
| | - D Wichterle
- Institute for Clinical and Experimental Medicine (IKEM), Department of Cardiology, Prague, Czech Republic
| | - A Pavlov
- Institute for Clinical and Experimental Medicine (IKEM), Department of Cardiology, Prague, Czech Republic
| | - T Gokdeniz
- Institute for Clinical and Experimental Medicine (IKEM), Department of Cardiology, Prague, Czech Republic
| | - P Peichl
- Institute for Clinical and Experimental Medicine (IKEM), Department of Cardiology, Prague, Czech Republic
| | - B Aldhoon
- Institute for Clinical and Experimental Medicine (IKEM), Department of Cardiology, Prague, Czech Republic
| | - J Franekova
- Institute for Clinical and Experimental Medicine (IKEM), Department of Biochemistry, Prague, Czech Republic
| | - J Kautzner
- Institute for Clinical and Experimental Medicine (IKEM), Department of Biochemistry, Prague, Czech Republic
| |
Collapse
|
8
|
Benes J, Kotrc M, Wohlfahrt P, Conrad M, Franekova J, Jabor A, Lupinek P, Kautzner J, Melenovsky V, Jarolim P. P3390GDF-15 augments BNP-based risk prediction in patients with chronic systolic heart failure and kidney disease. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p3390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
9
|
Hoskova L, Franekova J, Malek I, Kautzner J, Pirk J, Szarszoi O, Jabor A, Viklicky O, Melenovsky V. Early Diagnosis of Acute Kidney Injury After Heart Transplantation - The Prominent Role of Cystatin-C. J Heart Lung Transplant 2015. [DOI: 10.1016/j.healun.2015.01.156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
10
|
Pazdernik M, Malek I, Melenovsky V, Maxian R, Binova J, Franekova J, Jabor A, Karmazin V, Hegarova M, Kautzner J. Cardiac Allograft Vasculopathy Assessed By Quantitative Coronary Angiography: A Single Center Prospective Study. J Heart Lung Transplant 2015. [DOI: 10.1016/j.healun.2015.01.836] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
11
|
Jabor A, Franekova J. [Not Available]. Vnitr Lek 2013; 59:953-954. [PMID: 24432462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
|
12
|
Hoskova L, Franekova J, Malek I, Secnik P, Pirk J, Kautzner J, Szarszoi O, Jabor A. The Value of Cardiorenal Biomarkers for Prediction of Renal Dysfunction after Heart Transplantation. J Heart Lung Transplant 2013. [DOI: 10.1016/j.healun.2013.01.508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
13
|
Rydlova M, Holubec L, Ludvikova M, Kalfert D, Franekova J, Povysil C, Ludvikova M. Biological activity and clinical implications of the matrix metalloproteinases. Anticancer Res 2008; 28:1389-1397. [PMID: 18505085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
The family of human matrix metalloproteinases (MMPs) comprises several tightly regulated classes of proteases. These enzymes and their specific inhibitors play important roles in tumour progression and the metastatic process by facilitating extracellular matrix degradation. As scientific understanding of the MMPs has advanced, therapeutic strategies focusing on blocking these enzymes by matrix metalloproteinase inhibitors have rapidly developed. Low molecular weight tissue inhibitors of matrix metalloproteinase (TIMPs) represent a new therapeutic approach for the treatment of individual types of cancer. This paper aims to briefly summarize current knowledge about the role of MMPs in select non- tumorous lesions, tumor invasion and metastasis. The perspectives in therapeutic intervention in cancer are also mentioned. The role of MMPs in diagnosis and prognosis of colorectal and thyroid cancer is discussed in detail.
Collapse
Affiliation(s)
- M Rydlova
- Department of Pathology, Medical Social Faculty of University of Ostrava, Czech Republic
| | | | | | | | | | | | | |
Collapse
|
14
|
Raslova K, Gasparovic J, Franekova J, Fabryova L, Kovac G, Stavny J, Rajecova E, Belosovicova M, Babjak M, Vohnout B. W09.252 Familial defective APOB-100 in Slovak patients with primary hypercholesterolemia. ATHEROSCLEROSIS SUPP 2004. [DOI: 10.1016/s1567-5688(04)90251-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|